The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Induction of Immunological Tolerance by Apoptotic Cells Requires Caspase-Dependent Oxidation of High-Mobility Group Box-1 Protein
Open accessAbstract
The mammalian immune system discriminates between modes of cell death; necrosis often results in inflammation and adaptive immunity, whereas apoptosis tends to be anti-inflammatory and promote immune tolerance. We have examined apoptosis for the features responsible for tolerance; specifically, we looked at the roles of caspases and mitochondria. Our results show that caspase activation targeted the mitochondria to produce reactive oxygen species (ROS), which were critical to tolerance induction by apoptotic cells. ROS oxidized the potential danger signal high-mobility group box-1 protein (HMGB1) released from dying cells and thereby neutralized its stimulatory activity. Apoptotic cells failed to induce tolerance and instead stimulated immune responses by scavenging or by mutating a mitochondrial caspase target protein when ROS activity was prohibited. Similarly, blocking sites of oxidation in HMGB1 prevented tolerance induction by apoptotic cells. These results suggest that caspase-orchestrated mitochondrial events determine the impact of apoptotic cells on the immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“That said, it should be noted that biological activities of HMGB1 may flip from pro-inflammatory to anti-inflammatory depending on multiple variables including its oxidation state [917–923].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [921]
In the citing paper
“Potential immunogenic signals emanating from dying cells include proteins that appear at the surface of stressed and dying cells (such as calreticulin and heat shock proteins, HSPs), lipid moieties that flip from the inner plasma membrane leaflet to the outer leaflet (such as phosphatidylserine) 38,60, proteins that are released into the supernatant of cells (such as HMGB1) 51, as well as nucleic”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [51]
In the citing paper
“The inhibition of caspases affects the exposure of find-me signals 40, eat-me signals 40 (Box 4), and the secretion of DAMPs51 from dying cells, as well as the exposure of CRT on anthracyclin-treated cancer cells60.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [51]
In the citing paper
“Thus, HMGB1 may act on the receptor for advanced glycated endproducts (RAGEs) and possibly the toll-like receptors (TLRs) including TLR2 and TLR4 51,52, although the latter are controversial 53.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,263
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166 · cited 4×
“Although these mediators can stimulate immunity, apoptotic cells can inhibit inflammatory and immunological responses driven by macrophages and DCs (Fadok et al., 1998).”
BackgroundInfluentialSteinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,162
Apoptosis: controlled demolition at the cellular level
Taylor, R. C., Cullen, S. P., & Martin, S. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2312 · Cited by 2,708
Mitochondria, oxidative stress and cell death
Ott, M., Gogvadze, V. G., Orrenius, S., & Zhivotovsky, B. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0756-2 · Cited by 2,020
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 626
Voloshin, T., Kaynan, N., Davidi, S., Porat, Y., Shteingauz, A., Schneiderman, R. S., Zeevi, E., Munster, M., Blat, R., Tempel-Brami, C., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02534-7 · Cited by 189
Cell Death and DAMPs in Acute Pancreatitis
Kang, R., Lotze, M. T., Zeh, H. J., Billiar, T. R., & Tang, D. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00117 · Cited by 182
Hubert, P., Roncarati, P., Demoulin, S., Pilard, C., Ancion, M., Reynders, C., Lerho, T., Bruyère, D., Lebeau, A., Radermecker, C., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001966 · Cited by 191
Necroptosis‐Inducible Polymeric Nanobubbles for Enhanced Cancer Sonoimmunotherapy
Um, W., Ko, H., You, D. G., Lim, S., Kwak, G., Shim, M. K., Yang, S., Lee, J., Song, Y., Kim, K., et al. (2020) · Advanced Materials · doi:10.1002/adma.201907953 · Cited by 168
Nagy, C., & Haschemi, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00164 · Cited by 171
Redox Modulation of HMGB1-Related Signaling
Janko, C., Filipović, M. R., Munoz, L. E., Schorn, C., Schett, G. A., Ivanović‐Burmazović, I., & i, M. H. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5179 · Cited by 171
Demoulin, S., Herfs, M. F., Delvenne, P., & Hubert, P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0812397 · Cited by 170
Targeting the complement system for the management of retinal inflammatory and degenerative diseases
Xu, H., & Chen, M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.03.001 · Cited by 168
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target
Lou, H., Ling, G. S., & Cao, X. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102861 · Cited by 175
The sterile immune response during hepatic ischemia/reperfusion
van Golen, R. F., van Gulik, T. M., & Heger, M. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.006 · Cited by 163
Eat-Me: Autophagy, Phagocytosis, and Reactive Oxygen Species Signaling
Vernon, P. J., & Tang, D. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4810 · Cited by 161
DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown
Garg, A. D., Krysko, D. V., Vandenabeele, P., & Agostinis, P. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c0pp00294a · Cited by 157
Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy
Rapoport, B. L., & Anderson, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040959 · Cited by 156
Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation
Deng, M., Scott, M. J., Fan, J., & Billiar, T. R. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir1218-497r · Cited by 153
Lü, B., Wang, C., Wang, M., Li, W., Chen, F., Tracey, K. J., & Wang, H. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.909730 · Cited by 153
Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications
Boyapati, R. K., Rossi, A. G., Satsangi, J., & Ho, G. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.14 · Cited by 150
Yao, X., Carlson, D., Sun, Y., Ma, L., Wolf, S. E., Minei, J. P., & Zang, Q. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139416 · Cited by 148
HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis
de Souza, A. W. S., Westra, J., Limburg, P. C., Bijl, M., & Kallenberg, C. G. M. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.03.007 · Cited by 145
High-mobility group box family of proteins: ligand and sensor for innate immunity
Yanai, H., Ban, T., & Taniguchi, T. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.10.005 · Cited by 146
Targeting HMGB1 in the treatment of sepsis
Wang, H., Ward, M. F., & Sama, A. E. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.863876 · Cited by 144
Sun, Q., Wu, W., Hu, Y.-C., Li, H., Zhang, D.-D., Li, S., Li, W., Li, W.-D., Ma, B., Zhu, J., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-106 · Cited by 141
Diabetic retinopathy and dysregulated innate immunity
Xu, H., & Chen, M. (2017) · Vision Research · doi:10.1016/j.visres.2017.04.013 · Cited by 144
Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
Radogna, F., & Diederich, M. F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.006 · Cited by 146
TLR activation regulates damage‐associated molecular pattern isoforms released during pyroptosis
Nyström, S., Antoine, D. J., Lundbäck, P., Lock, J. G., Niță, A. F., Högstrand, K., Grandien, A., Erlandsson-Harris, H., Andersson, U., & Applequist, S. E. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.328 · Cited by 138
Wähämaa, H., Schierbeck, H., Hreggvidsdottir, H. S., Palmblad, K., Aveberger, A.-C., Andersson, U., & Harris, H. E. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3450 · Cited by 138
Crashing the computer: apoptosis vs. necroptosis in neuroinflammation
Heckmann, B. L., Tummers, B., & Green, D. R. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0195-3 · Cited by 136
Self-citationCell Death-Associated Molecular-Pattern Molecules: Inflammatory Signaling and Control
Sangiuliano, B. A., Pérez-Sosa, M., Moreira, D., & Belizário, J. E. (2014) · Mediators of Inflammation · doi:10.1155/2014/821043 · Cited by 142
Regulation of Posttranslational Modifications of HMGB1 During Immune Responses
Tang, Y., Zhao, X. S., Antoine, D. J., Xiao, X., Wang, H., Andersson, U., Billiar, T. R., Tracey, K. J., & Lü, B. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6409 · Cited by 132
Zhai, J., Gu, X., Liu, Y., Hu, Y., Jiang, Y., & Zhang, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1152934 · Cited by 131
Programmed Cell Death and Inflammation: Winter Is Coming
Kolb, J. P., Oguin, T. H., Oberst, A., & Martinez, J. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.06.009 · Cited by 136
Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury
Deng, C., Zhao, L., Yang, Z. P., Shang, J., Wang, C., Shen, M., Jiang, S., Tian, L., Di, W., Chen, Y., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00676-7 · Cited by 139
Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases
Chen, R., Hou, W., Zhang, Q., Kang, R., Fan, X., & Tang, D. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00099 · Cited by 130
HMGB1 as a Key Mediator of Immune Mechanisms in Ischemic Stroke
Singh, V., Roth, S., Veltkamp, R. C., & Liesz, A. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6397 · Cited by 130
Emerging Roles for HMGB1 Protein in Immunity, Inflammation, and Cancer
Ranzato, E., Martinotti, S., & Patrone, M. (2015) · ImmunoTargets and Therapy · doi:10.2147/itt.s58064 · Cited by 127
Eloranta, M., Lövgren, T., Finke, D., Mathsson, L., Rönnelid, J., Kastner, B., Alm, G. V., & Rönnblom, L. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24686 · Cited by 129
Dangerous attraction: phagocyte recruitment and danger signals of apoptotic and necrotic cells
Peter, C., Wesselborg, S., i, M. H., & Lauber, K. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0472-1 · Cited by 136
Danger signals in liver injury and restoration of homeostasis
Han, H., Desert, R., Das, S., Song, Z., Athavale, D., Ge, X., & Nieto, N. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.033 · Cited by 127
The Danger Hypothesis Applied to Idiosyncratic Drug Reactions
Li, J., & Uetrecht, J. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_18 · Cited by 130
The Antisocial Network: Cross Talk Between Cell Death Programs in Host Defense
Snyder, A. G., & Oberst, A. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-112019-072301 · Cited by 129
Ferroptosis in immunostimulation and immunosuppression
Tang, D., Kroemer, G., & Kang, R. (2023) · Immunological Reviews · doi:10.1111/imr.13235 · Cited by 129
Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity
Fontana, P., Du, G., Zhang, Y., Zhang, H., Vora, S. M., Hu, J. J., Shi, M., Tufan, A. B., Healy, L. B., Xia, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.007 · Cited by 134
NOVEL HMGB1-INHIBITING THERAPEUTIC AGENTS FOR EXPERIMENTAL SEPSIS
Wang, H., Ward, M. F., & Sama, A. E. (2009) · Shock · doi:10.1097/shk.0b013e3181a551bd · Cited by 125
The role of HMGB1 in the pathogenesis of rheumatic disease
Andersson, U., & Harris, H. E. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.003 · Cited by 126
The Role of High Mobility Group Box 1 in Innate Immunity
Lee, S.-A., Kwak, M. S., Kim, S., & Shin, J. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.5.1165 · Cited by 123
Chen, B., Miller, A. L., Rebelatto, M. C., Brewah, Y. A., Rowe, D. C., Clarke, L., Czapiga, M., Rosenthal, K., Imamichi, T., Chen, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115828 · Cited by 131
Adaptive immunity after cell death
Zelenay, S., & Sousa, C. R. E. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.005 · Cited by 129
Mitochondria as decision‐makers in cell death
Borutaitė, V. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20564 · Cited by 123
Prospects for therapeutic mitochondrial transplantation
Gollihue, J. L., & Rabchevsky, A. G. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.05.007 · Cited by 125
Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer?
Lemarié, A., & Grimm, S. (2011) · Oncogene · doi:10.1038/onc.2011.167 · Cited by 126
The dual role and therapeutic potential of high-mobility group box 1 in cancer
He, S.-J., Cheng, J. Q., Xiao, F., Yu, Y., Tian, L., & Huang, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.17885 · Cited by 126
Bluestone, J. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01019.x · Cited by 130
Apoptotic Cells Induced Signaling for Immune Homeostasis in Macrophages and Dendritic Cells
Trahtemberg, U., & Mevorach, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01356 · Cited by 125
The innate immune system in diabetic retinopathy
Pan, W. W., Lin, F., & Fort, P. E. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100940 · Cited by 117
Oca, R. M. D., Alavi, A., Vitali, N., Bhattacharya, S., Blackwell, C., Patel, K. J., Seestaller‐Wehr, L., Kaczynski, H., Shi, H., Dobrzynski, E., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0035 · Cited by 123
The immunogenicity of tumor cell death
Kepp, O., Tesnière, A., Zitvogel, L., & Kroemer, G. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32831bc375 · Cited by 124
HMGB1 protein as a novel target for cancer
Tripathi, A. S., Shrinet, K., & Kumar, A. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.03.002 · Cited by 116
Immunogenic Cell Death: Can It Be Exploited in PhotoDynamic Therapy for Cancer?
Panzarini, E., Inguscio, V., & Dini, L. (2012) · BioMed Research International · doi:10.1155/2013/482160 · Cited by 120
Fu, L., Liu, K., Wake, H., Teshigawara, K., Yoshino, T., Takahashi, H. K., Mori, S., & Nishibori, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01325-y · Cited by 115
A Janus Tale of Two Active High Mobility Group Box 1 (HMGB1) Redox States
Tang, D., Billiar, T. R., & Lotze, M. T. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00314 · Cited by 112
TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease
Jones, E. L., Laidlaw, S. M., & Dustin, L. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738473 · Cited by 112
Therapeutic potential of HMGB1-targeting agents in sepsis
Wang, H., Zhu, S., Zhou, R., Li, W., & Sama, A. E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000884 · Cited by 115
DAMPs and inflammatory processes: the role of redox in the different outcomes
Carta, S., Castellani, P., Delfino, L., Tassi, S., Venè, R., & Rubartelli, A. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008598 · Cited by 112
Eosinophils Oxidize Damage-Associated Molecular Pattern Molecules Derived from Stressed Cells
Lotfi, R., Herzog, G. I., DeMarco, R., Beer–Stolz, D., Lee, J. J., Rubartelli, A., Schrezenmeier, H., & Lotze, M. T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900504 · Cited by 111
van Golen, R. F., Reiniers, M. J., Vrisekoop, N., Zuurbier, C. J., Olthof, P. B., van Rheenen, J., van Gulik, T. M., Parsons, B. J., & Heger, M. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5751 · Cited by 116
A Systematic Nomenclature for the Redox States of High Mobility Group Box (HMGB) Proteins
Antoine, D. J., Harris, H. E., Andersson, U., Tracey, K. J., & Bianchi, M. E. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00022 · Cited by 108
Hreggvidsdottir, H. S., Lundberg, A. M., Aveberger, A.-C., Klevenvall, L., Andersson, U., & Harris, H. E. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00327 · Cited by 108
Armed response: how dying cells influence T‐cell functions
Ferguson, T. A., Choi, J., & Green, D. R. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01006.x · Cited by 118
Self-citationPotential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders
Paudel, Y. N., Angelopoulou, E., Semple, B. D., Piperi, C., Othman, I., & Shaikh, M. F. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00640 · Cited by 107
Thiol–Disulfide Exchange Reactions in the Mammalian Extracellular Environment
Yi, M. C., & Khosla, C. (2016) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-080615-033553 · Cited by 104
The impact of radiation therapy on the antitumor immunity: Local effects and systemic consequences
Lumniczky, K., & Sáfrány, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.024 · Cited by 103
Karuppagounder, V., Arumugam, S., Thandavarayan, R. A., Pitchaimani, V., Sreedhar, R., Afrin, R., Harima, M., Suzuki, H., Nomoto, M., Miyashita, S., et al. (2015) · Experimental Dermatology · doi:10.1111/exd.12685 · Cited by 103
High-mobility group box-1 and its role in angiogenesis
Yang, S., Xu, L., Yang, T., & Wang, F. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.0713412 · Cited by 104
Balogh, K. N., Templeton, D. J., & Cross, J. V. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197702 · Cited by 98
Antoine, D. J., Williams, D. P., Kipar, A., Laverty, H., & Park, B. K. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00126 · Cited by 102
RetractedHigh-mobility group box 1 (HMGB1) as a master regulator of innate immunity
Castiglioni, A., Canti, V., Rovere, P. Q., & Manfredi, A. A. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1033-1 · Cited by 104
The complex interplay between autophagy, apoptosis, and necrotic signals promotes T‐cell homeostasis
Walsh, C. M., & Edinger, A. L. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00919.x · Cited by 99
Immunogenic Apoptotic Cell Death and Anticancer Immunity
Vandenabeele, P., Vandecasteele, K., Bachert, C., Krysko, O., & Krysko, D. V. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-39406-0_6 · Cited by 106
Maugeri, N., Rovere, P. Q., Baldini, M., Baldissera, E. M., Sabbadini, M. G., Bianchi, M. E., & Manfredi, A. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5298 · Cited by 97
The immunosuppressive side of PDT
Mróz, P., & Hamblin, M. R. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c0pp00345j · Cited by 99
Immunological consequences of kidney cell death
Sarhan, M., von Mäßenhausen, A., Hugo, C., Oberbauer, R. W., & Linkermann, A. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0057-9 · Cited by 100
HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development
Abdulahad, D. A., Westra, J., Limburg, P. C., Kallenberg, C. G. M., & Bijl, M. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.05.015 · Cited by 96
Emerging role of HMGB1 in lung diseases: friend or foe
Ding, J., Cui, X., & Liu, Q. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13048 · Cited by 95
Guo, Z., Liu, Y., Chen, D., Sun, Y., Li, D., Meng, Y., Zhou, Q., Zeng, F., Deng, G., & Chen, X. (2025) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2025-0004 · Cited by 111
Immunogenic and Non-immunogenic Cell Death in the Tumor Microenvironment
Pitt, J. M., Kroemer, G., & Zitvogel, L. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_5 · Cited by 98
Wang, M., Gauthier, A. G., Daley, L.-A., Dial, K., Wu, J., Woo, J., Lin, M., Ashby, C. R., & Mantell, L. L. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7818 · Cited by 95
HMGB1 and repair: focus on the heart
Pellegrini, L., Foglio, E., Pontemezzo, E., Germani, A., Russo, M. A., & Limana, F. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.12.005 · Cited by 92
Kruse, K., Janko, C., Urbonaviciute, V., Mierke, C. T., Winkler, T., Voll, R. E., Schett, G. A., Munoz, L. E., & i, M. H. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0478-8 · Cited by 94
Cell Death in the Maintenance and Abrogation of Tolerance: The Five Ws of Dying Cells
Griffith, T. S., & Ferguson, T. A. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.011 · Cited by 95
Self-citationPepple, A., Guy, J., McGinnis, R. J., Felsted, A. E., Song, B., Hubbard, R. T., Worlikar, T., Garavaglia, H., Dib, J., Chao, H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1012799 · Cited by 91
Giacomini, C., Granéli, C., Hicks, R., & Dazzi, F. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01018-9 · Cited by 98
Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis?
Shields, A. M., Panayi, G. S., & Corrigall, V. M. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04433.x · Cited by 90
Huang, F., Lei, J., Sun, Y., Yan, F., Chen, B., Zhang, L., Lu, Z., Cao, R. Y., Lin, Y., Wang, C.-C., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1446720 · Cited by 90
Oxidative Modifications of DAMPs Suppress Inflammation: The Case for S100A8 and S100A9
Lim, S. Y., Raftery, M. J., & Geczy, C. L. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3641 · Cited by 91
Zandarashvili, L., Sahu, D., Lee, K., Lee, Y. S., Singh, P., Rajarathnam, K., & Iwahara, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.449942 · Cited by 89
The Alarmin Properties of DNA and DNA-associated Nuclear Proteins
Magna, M., & Pisetsky, D. S. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.02.029 · Cited by 90
Kwak, M. S., Kim, H. S., Lkhamsuren, K., Kim, Y. H., Han, M. G., Shin, J. M., Park, I. H., Rhee, W. J., Lee, S. K., Rhee, S. G., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101203 · Cited by 88
Guerriero, J. L., Ditsworth, D., Catanzaro, J. M., Sabino, G. J., Furie, M. B., Kew, R. R., Crawford, H. C., & Zong, W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003267 · Cited by 92
Allette, Y. M., Due, M. R., Wilson, S. M., Feldman, P., Ripsch, M. S., Khanna, R., & White, F. A. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.199 · Cited by 89
Armando Rojas, R., Delgado‐López, F., González, I., Pérez-Castro, R., Romero, J. A., & Rojas, I. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.11.022 · Cited by 86
Immunogenicity of ferroptosis in cancer: a matter of context?
Catanzaro, E., Demuynck, R., Naessens, F., Galluzzi, L., & Krysko, D. V. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.01.013 · Cited by 87
Metadata
- Authors
- Kazama, H., Ricci, J.-E., Herndon, J. M., Hoppe, G., Green, D. R., & Ferguson, T. A.
- Affiliations
- Washington University in St. Louis (US)
- Université Côte d'Azur (FR)
- Cleveland Clinic (US)
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Ferguson, Thomas A.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 29
- Issue
- 1
- Pages
- 21-32
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC2704496
- OpenAlex
- W2084623259
- Cited by
- 627
- References
- 60
- Citations by year
- 2026: 24 · 2025: 23 · 2024: 33 · 2023: 35 · 2022: 24 · 2021: 38 · 2020: 32 · 2019: 26 · 2018: 33 · 2017: 31 · 2016: 20 · 2015: 44 · 2014: 47 · 2013: 43 · 2012: 34
- FWCI
- 19.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Research to Prevent Blindness (EY02687)
- National Institutes of Health (AI44848, EY02687, EY06765)
- National Eye Institute (EY 02687, P30EY002687, EY 015570, F32EY006765, EY06765, R01EY015570, R01EY006765)
- National Institute of Allergy and Infectious Diseases (AI44848, R01AI044828, R01AI040646)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- immune tolerance, apoptotic cells, caspases, HMGB1, high mobility group box 1 protein, reactive oxygen species, oxidative modification, damage-associated molecular patterns, necrosis, tolerance induction
- MeSH terms
- Animals, Dendritic Cells, HeLa Cells, Humans, Immune Tolerance, Mice, Inbred C57BL, Mitochondria, Oxidation-Reduction, Immunoblotting, Apoptosis, Reactive Oxygen Species, Caspases, HMGB1 Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
